No: AH 03052021 May 17, 2021 Subject: Management Discussion & Analysis (MD&A) for the financial statements of the 1st quarter of fiscal year 2021 ended as of March 31, 2021 To: The President The Stock

No: AH 02112021 November 12, 2021 Subject: Management Discussion & Analysis (MD&A) for the financial statements of the 3rd quarter of fiscal year 2021 ended as of September 30, 2021 To: The President

No: AH 03052022 May 17, 2022 Subject: Management Discussion & Analysis (MD&A) for the Financial Statements of the 1st Quarter of Fiscal Year 2022 Ended as of March 31, 2022 To: The President The Stock

No: AH 02052023 May 11th, 2023 Subject: Management Discussion & Analysis (MD&A) for the Financial Statements of the 1st Quarter of Fiscal Year 2023 Ended as of March 31, 2023 To: The President The

…………………………….. Authorised person sign (…………………………….) on behalf of the applicant. Position ………………………………. Date ………………………………….. Affix the company’s seal (If any) Note: The Application and supporting documents according to the

correct. Signature …………………………….. Authorised person sign (…………………………….) on behalf of the applicant. Position ………………………………. Date ………………………………….. Affix the company’s seal (If any) Note: The Application and

Sign Co. Ltd., (“Multi Sign”) and COMASS Co. Ltd., (“COMASS”) which was acquired in October 2016 and July 2017, respectively. The consolidation has expanded MACO’s nationwide footprints and increased

law governing such Thai government agencies; (2) the financial statements and the consolidated financial statements of the Thai government agencies for the most recent year and the financial statements

foreign laws and regulations that such entity registered; (3) the financial statements of the foreign entity and its consolidated financial statements for the most recent accounting year and the financial

. In disclosing risks associated with derivatives trading under Paragraph 1, the derivatives broker shall sign on the risk disclosure statement to certify that it has given an explanation of the risks